Literature DB >> 26793372

Is staging mediastinoscopy necessary before stereotactic body radiotherapy for inoperable early stage lung cancer?

Jean-Claude M Rwigema1, Percy Lee1.   

Abstract

Entities:  

Year:  2015        PMID： 26793372      PMCID： PMC4703637          DOI： 10.3978/j.issn.2072-1439.2015.12.54

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.

Authors:  Sashendra Senthi; Frank J Lagerwaard; Cornelis J A Haasbeek; Ben J Slotman; Suresh Senan
Journal:  Lancet Oncol       Date:  2012-06-22       Impact factor: 41.316

3.  Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer.

Authors:  Atsuya Takeda; Etsuo Kunieda; Naoko Sanuki; Yousuke Aoki; Yohei Oku; Hiroshi Handa
Journal:  Lung Cancer       Date:  2012-01-31       Impact factor: 5.705

4.  Survival of patients with true pathologic stage I non-small cell lung cancer.

Authors:  Robert J Cerfolio; Ayesha S Bryant
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

5.  Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.

Authors:  Jingbo Wang; Kathy Welch; Luhua Wang; Feng-Ming Spring Kong
Journal:  Clin Lung Cancer       Date:  2011-11-03       Impact factor: 4.785

6.  Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.

Authors:  R Feld; L V Rubinstein; T H Weisenberger
Journal:  J Clin Oncol       Date:  1984-12       Impact factor: 44.544

7.  Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial.

Authors:  Lucio Trodella; Pierluigi Granone; Salvatore Valente; Vincenzo Valentini; Mario Balducci; Giovanna Mantini; Adriana Turriziani; Stefano Margaritora; Alfredo Cesario; Sara Ramella; Giuseppe M Corbo; Rolando M D'Angelillo; Antonella Fontana; Domenico Galetta; Numa Cellini
Journal:  Radiother Oncol       Date:  2002-01       Impact factor: 6.280

8.  Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?

Authors:  H Asamura; H Nakayama; H Kondo; R Tsuchiya; Y Shimosato; T Naruke
Journal:  J Thorac Cardiovasc Surg       Date:  1996-06       Impact factor: 5.209

Review 9.  Systemic effects of local radiotherapy.

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  Lancet Oncol       Date:  2009-07       Impact factor: 41.316

10.  Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.

Authors:  Nael Al-Sarraf; Rashid Aziz; Kathy Gately; Julie Lucey; Lorraine Wilson; Eillish McGovern; Vincent Young
Journal:  Eur J Cardiothorac Surg       Date:  2007-10-30       Impact factor: 4.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.